LexDanaLexDanabeta
New SessionSearchOfficial RankingsInsightsPricing
© LexDana · beta
LexDanaLexDanabeta
New SessionSearchOfficial RankingsInsightsPricing
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets14Federal Circuit179Pharma & ANDA40PTAB150Supreme Court9USPTO Policy27Patent Litigation55Patent Prosecution20ITC / Section 33732Trademark43Unsorted35

Tagged discretionary denial · clear

PTAB

PTAB in 2026: What Practitioners Are Getting Wrong

Institution rates have moved, but the reasoning behind them has moved further. The number most petitions still cite is the headline institution rate — and it has not been the operative number for two years. The two stage problem A petition now has to…

July 29, 2026·PTAB·1 min read
LexDana
AskSearchRankingsInsightsPricingProfileContactTermsPrivacy
The LexDana Docket
Monthly — what shipped, who moved, what we published.
© 2026 LexDana, Inc.·Powered by Patexia data